Results 131 to 140 of about 15,201 (184)

Deciphering the role of PTPN6 in aberrant signaling and BLCA prognosis

Discover Biotechnology
Muhammad Tahir, Muhammad Suffian, Noshaba Dilbar, Sajjad Hussain, Amir Ejaz   +4 more
openaire   +1 more source

Integrative multi-omics and single-cell transcriptomics reveal ARHGEF12 driving chemoresistance in bladder cancer. [PDF]

Hereditas
Zhu K, Zhang Z, Li T, Sun Y, Zhu J, Wu L, Zhang X, Tong H, Qin Z, Wang A, He W.   +10 more
europepmc   +1 more source

Combining machine learning and molecular docking to unravel the molecular network of bladder cancer induced by 2-naphthylamine. [PDF]

Discov Oncol
Qin R, Li C, Liu C, Shen C, Hu D, Zhao X, Ge H, Zhu J, Wang Y.   +8 more
europepmc   +1 more source

Integrin β4 drives immune evasion and therapeutic resistance to PD-1 blockade in bladder cancer via MEK/ERK signaling. [PDF]

J Biol Chem
Lin P, Xing Z, Hong Y, Xu H, Shao S, Luo L, Zhao Y, Jin X, Li Y.   +8 more
europepmc   +1 more source

A novel tumor-progressing fibroblast signature derived from single-cell RNA sequencing enables prognostic stratification and reveals RNF11 as a functional regulator in bladder cancer. [PDF]

Front Mol Biosci
Zhang M, Lin L, Xu H, Su X, Zeng K, Zhong F, Su X, Chen J, Cao M, Yu H, Zhuo H.   +10 more
europepmc   +1 more source

Elucidating a novel prognostic signature for bladder cancer by integrating hypoxia and lactate metabolism-related genes: comprehensive bioinformatics analyses and experimental evidence. [PDF]

BMC Cancer
Zhao Y, Li P, Shen Z, Yao S, Zhang X, Zhang N, Chen J.   +6 more
europepmc   +1 more source

PSMD8 cooperates with USP14 to promote bladder cancer progression by inhibiting ferroptosis. [PDF]

iScience
Wang X, Liu B, Tang Y, Wang J, Ren J, Hu R, Chen W, Fu D, Wu Y, Gui T, Wang J, Han P, Wei X, Li H, Bai Y.   +14 more
europepmc   +1 more source

LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway. [PDF]

Clin Exp Med
Li Y, Zhao B, Gao W, Wu Y, Tian T, Zhao S, Zhang J, Li R, He S, Gong Y, Ma J, Li X.   +11 more
europepmc   +1 more source

Sphingolipid Metabolism Dysregulation Drives Immune Microenvironment Remodeling and Predicts Prognosis in Bladder Cancer. [PDF]

Int J Genomics
Peng Z, Yang J, Jia R, Wu T, Zhao S.
europepmc   +1 more source

Transient Receptor Potential Melastatin 4 (TRPM4) is associated with an immuno-stimulatory TME and better prognosis in BLCA. [PDF]

Discov Oncol
Da Y, Chen X, Yu L, Li Y, Chen Z, Zhang Y, Wang H, Zhu Z, Liu Y, Geng Y.   +9 more
europepmc   +1 more source